The German biotechnology market is expected to grow at a CAGR of 10.70% from 2024 to 2032. Key drivers of this growth include advancements in genomics and molecular biology, rising demand for personalized medicine, the increasing prevalence of chronic diseases, government support, and innovations in biopharmaceuticals and agricultural biotechnology. https://www.imarcgroup.com/germany-biotechnology-market